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Abstract 
Background: Epilepsy is the world’s most common neurological disorder, affecting approximately 50 million people 
worldwide and contributed to different psychiatric illness. Depression is one of the most frequent co morbid psychiat-
ric disorders that affects the life of the patients’. This study aimed to assess the prevalence of depression and associ-
ated factors among epileptic patients attending the outpatient department of the University of Gondar Hospital, 
Northwest Ethiopia, 2014.
Methods: Institution based quantitative cross—sectional study was conducted among 405 individual with epilepsy. 
The participants were selected using systematic random sampling technique. Semistructured questionnaires were 
used to obtain socio-demographic and clinical data. Depression was measured using Beck’s Depression Inventory 
Binary logistic regression used for analysis.
Results: The estimated, prevalence of depression was found to be 45.2 %. Out of these (29.6 %) were classified as 
mild, (14.8 %) as moderate and (0.8 %) were severely depressed. A lower educational status was associated with an 
increased prevalence of depression and the adjusted odds ratio (AOR) for the illiterate [can’t read and write] was 
8.32 [95 % Confidence Interval (CI): 4.83, 14.29]. Perceived stress (AOR = 6.21, CI 3.69, 10.44), onset of illness <6 years 
(AOR = 5.29, CI 4.09, 15.89), seizure frequency of [1–11 per year (AOR = 1.34, CI 1.41, 4.36), ≥1 per month (AOR = 7.83, 
CI 3.52, 17.40)], poly-pharmacy (AOR = 7.63, CI 2.74, 21.26)] and difficulties of adherence to antiepileptic drugs 
(AOR = 4.80, CI 2.57, 8.96) were also found to be independently associated with depression.
Conclusion: Overall, the prevalence of depression was found to be high. Lower educational status, early onset of 
illness, seizure frequency, poly-pharmacy and difficulties of adherence to anti-epileptic drugs (AEDs) were factors 
statistically associated with depression. Strengthening the educational status of the patients on the effect of early 
onset of the illness, frequent seizure occurrence and difficulty of adherence to AEDs as a contributing factors for other 
co-morbid psychiatric disorder are suggested in the clinical care setting.
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Background
Epilepsy is the world’s most common neurological disor-
der, affecting approximately 50 million people worldwide, 
and the majority of whom (80–85  %) live in resource-
poor countries [1]. The prevalence of epilepsy in African 
ranges from 2.2 to 58 per 1000 population and consti-
tutes the second or third reason for consultation and hos-
pitalization [2].
In Ethiopia, epilepsy is a huge problem, which affects 
about 5.2 per 1000 population [3, 4] with an estimation of 
about 0.5 % of patients with active epilepsy (with seizers 
in the past 1–2 years). The existing studies also revealed 
that individuals with epilepsy suffer from a number of 
social, psychological and physical poor outcomes. For 
example a study conducted in Ethiopia revealed that 60 % 
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of the study participants faced different problems as a 
result of their illness such as stigma by 24 %, inability to 
find a partner by 31 %, educational problems by 17 %, and 
problems of employment by 9 % of adults [5]. That is why 
in a recently released Ethiopian Mental Health Strategic 
Plan, give emphasis to epileptic patients to be seen as one 
of the special vulnerable groups that require special con-
sideration [6].
According to World Health Organization mental ill-
ness is one of the greatest causes of disability universally. 
Five out of the ten leading causes of disability worldwide 
can be attributed to psychiatric disorders [7]. Depression 
is one of the leading causes of disability in the world. It 
is expected to be the second leading cause of disability 
worldwide by 2020 [8]. In Ethiopia, mental illness is the 
leading non-communicable disorder in terms of burden 
with schizophrenia and depression included in the top 
ten most burdensome conditions, out-ranking HIV/AIDS 
[6].
Research evidences had been revealed the multidirec-
tional links between mental and physical health and ill-
ness [9]. Thoughts, feelings and health behaviour have a 
major impact on physical health status. Conversely, phys-
ical health status considerably influences mental health 
and well-being [10, 11].
Depression is one of the co-existing psychiatric dis-
orders with chronic illnesses such as epilepsy [1, 2] that 
show a bidirectional interaction with epilepsy. For exam-
ple, a cross sectional study revealed that up to 60  % of 
epileptic patients developed depression and the presence 
of depression also increase risk of epilepsy up to 3–7 fold 
[12]. A comparative study have also shown that the rate 
of depression in patients with epilepsy is significantly 
higher than the rate of depression in patients with other 
chronic diseases such as diabetes or asthma and the gen-
eral population as well [13].
The presence of depression among epileptic patients 
can be associated with different psycho-social difficulties 
on patients life such as poor treatment adherence, poor 
quality of life, unemployment, lower educational status, 
increase burden and cost on healthcare services and 
higher risk for suicide [12–15].
Many studies from the Western world have reported 
on the prevalence of depression among people with 
epilepsy and its negative consequences, but few stud-
ies have addressed the issue in developing countries. 
The few studies conducted in Africa reported the wide-
spread existence of depression among epileptic patients. 
However, the available studies from Western and some 
African countries demonstrate high prevalence and 
negative consequences of depression. In Ethiopia, is the 
authors could find only one previously published study 
concerning the prevalence of depression among epileptic 
patients that reported from the Western part of Ethio-
pia that has a different socio cultural diversity (in Ethio-
pia within differences ethnic groups there are different 
language, religion, belief in disease causation) from our 
study area that may contribute for the variation of illness 
[16].
Yet, in the Northern part of the country where the cul-
ture of the community is fairly different from the Western 
part of the country (Ethiopia), there is a need to under-
stand the prevalence and its contributing factors. There-
fore, looking at the diverse problem related to depression, 
assessing the prevalence and predictors of depression are 
important to design more effective treatment programs 
for the management and preventions of its consequences. 
Thus, the main purpose of this study was to assess the 
prevalence and associated factors of depression among 
people with epilepsy at University of Gondar Hospital, 
North West Ethiopia, 2014.
Methods
Study design
Institution based cross-sectional study design was used.
Study area and period
The study was conducted at the University of Gondar 
Hospital (UoGH) from January 01/2014, to Febru-
ary 30/2014. Gondar town is located in North Gondar 
Administrative Zone of Amhara National, Regional State, 
748  km away from the capital city of Ethiopia, Addis 
Ababa. University of Gondar Hospital serves about 5 mil-
lion people in the catchment area. It has 400 beds in five 
different inpatient departments and 14 wards.
Participants
Participants of this study were individuals with epilepsy 
receiving follow-up care at the outpatient department 
of the University of Gondar Hospital. Single population 
proportion formula (with a 5 % margin of error, 95 % con-
fidence level and 49.3 % proportion) was used to calculate 
sample size; and it was found to be 422 (including 10 % 
non response rate). The total number of patients who vis-
ited the hospital for the last 12 months were taken from 
patient records and then the average number of patients 
per day calculated and then sampling fraction was deter-
mined. Finally, participants were selected by systematic 
random sampling technique every one interval starting 
from the first patient visiting the epileptic clinic and then 
continued to the third.
All were consenting individuals with a clinical diagno-
sis of epilepsy coming for follow up with an age greater 
than or equal to 18 years were selected. Individuals with 
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epilepsy who were critically ill (can’t give response), una-
ble to speak and hear were excluded from the study.
Instrument
For the assessment of depression, Beck Depression 
Inventory (BDI) was used. BDI is one of the most widely 
used self report measures of depression. It is a reliable 
and valid measure of depression in a range of cultural 
groups and has been validated with both psychiatric 
and non-psychiatric populations in most of the coun-
tries including Africa. It consists of 21 items, and each 
of its items describes a specific symptom of depres-
sion. A more recent version of the instrument (BDI-II) 
was used to correspond to DSM-IV criteria for depres-
sion. BDI-II used for screening of recent (during past 
2 weeks) depression symptoms in persons with epilepsy. 
Each statement is scored on a 4-point scale (0–3) and a 
total score is obtained by summing the ratings for each 
statement [17]. The prevalence of depression was defined 
using a cutoff point ≥10 on BDI-II as having depression. 
A score from 0 to 9 is considered to be within the normal 
range or asymptomatic; a score of 10–18 indicates mild 
depression; a score of 19–29 indicates moderate depres-
sion and a score of 30 or more severe depression [18, 19].
The questionnaires were translated into Amharic (local 
language) by an Amharic speaking linguist. The back-
translation was performed by mental health specialist 
into English and then a consensus version was developed 
in a group discussion by involving the research team. 
This was compared with the original version, and con-
firmed to be satisfactory for use. The questionnaires were 
tested on 21 patients to make it easier for the participants 
to understand and complete. In this study, BDI-II had an 
internal consistence of Cronbach’s alpha 0.856 for the 
total score.
For the assessment of the stress, Perceived Stress Scale 
(PSS) was used. The PSS is the most widely used psy-
chological tool for measuring the perception of stress. 
The questions in the PSS asked about the feelings and 
thoughts of the patients during the past month. Each 
item is rated on a 5-point scale ranging from never (0) 
to almost always [4]. Positively worded items are reverse 
scored, and the ratings are summed, with higher scores 
indicating more perceived stress. The presence of per-
ceived stress was defined using a cutoff point ≥20 on 
PSS. PSS had an internal consistence of Cronbach’s alpha 
for the total score of PSS = 0.793 [20].
Furthermore, we asked one question on antiepilep-
tic medication adherence. The antiepileptic medication 
adherence question asked about the history of non-
adherence with antiepileptic medications with yes/no 
response. Specifically, we asked “Have you ever discon-
tinued your antiepileptic medication?” Family history 
of mental illness was assessed by the question, ‘has any 
member of your family (immediate family- parent, sib-
ling, child) ever been diagnosed with a psychiatric disor-
der?’ Possible responses to this question were: (a) Yes (b) 
No. Family social support was assessed by the question 
‘How do you rate your social support (immediate fam-
ily—parent, sibling, child)?’ Possible responses to this 
question were: (a) Low, (b) Moderate, (c) High and the 
presence of seizer frequency was assessed by the ques-
tion, ‘Do you have a seizer for the last 12 months?’ Possi-
ble responses to this question were: (a) Yes (b) No. If yes, 
how many times?
Data collection and analysis
Data were collected by face-to-face interview using a 
semi-structured questionnaire with the Amharic version 
of the socio-demographic, clinical factors, and BDI-II 
questionnaires.
EPI info version 3.5.3 statistical software and SPSS 
windows version 16 program were used for analysis. 
Descriptive statistics (frequencies, tables, percentages, 
means and standard deviation) were used for the socio-
demographic and clinical variables, including individual’s 
response BDI-II. Binary logistic regression and odds ratio 
with 95  % confidence interval were used to identify the 
independently associated factors with depression.
All factors with a p value <0.2 in the bivariate logis-
tic regression were entered into the multivariate model. 
Statistical significance was accepted at the 5  % level 
(p < 0.05).
Ethical consideration
The study proposal was initially approved by the ethi-
cal review board of The University of Gondar. A for-
mal letter of permission was obtained from the hospital 
and submitted to the respective outpatient department. 
The information about the study was given to the par-
ticipants. Verbal and then written informed consent was 
sought for each participant who agreed to participate in 
the study and full filled the inclusion criteria. Only anon-
ymous data collected in private rooms.
Results
A total of 405 participants participated in this study with 
a 96 % response rate. Seventeen questioners were not ful-
filled properly or incomplete.
Socio‑demographic and clinical characteristics 
of participants
The majority of the participants were men 255 (63 %). The 
mean ages of the participants were 28.75  ±  9.65  years. 
One hundred and ninety-five (48.1 %) of the participants 
were primary educated, 372 (91.9  %) were Orthodox 
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and 246 (60.7  %) were married. Three hundred and 
eighty-four (94.8 %) of the participants were Amhara by 
Ethnicity. Out of 405 participants, 240 (59.2 %) were self-
employed and 213 (52.6 %) were living in urban areas.
And regarding their clinical characteristics, the mean 
age of disease onset was 20.99 ± 11.16 years. The mean 
duration of disease was 8.11 ± 6.63. Out of 405 patients, 
291 (71.8  %) had seizure frequency range from 1 to 11 
times per year. Three hundred and nine (76.3  %) of the 
participants were treated with one AED (mono-therapy), 
132 (32.6 %) had a history of non adherence to AEDs and 
18 (4.4 %) had a family history of mental illness (Table 1).
Prevalence of depression
Overall, the prevalence of depression was found to be 
45.2 %. Out of these (29.6 %) mild, (14.8 %) moderate and 
(0.8 %) were severe depression.
Factors associated with depression
From the bivariate analysis: age, educational statuses, 
social support, perceived stress, the onset of the illness, 
seizure frequency, poly-pharmacy, adherence to AEDs 
and family history of mental illness were factors associ-
ated with depression. On the other hand; sex, religion, 
marital status, ethnicity, residence, employment and 
duration of the illness were not associated with depres-
sion and excluded from further analysis.
From the multivariate analysis; education status [can’t 
read and write (AOR = 8.32, CI 4.826, 14.294), primary 
(AOR = 6.02, CI 3.727, 9.292), secondary (AOR = 4.00, 
CI 4.102, 8.251)], perceived stress (AOR  =  6.21, CI 
3.691, 10.442), onset of illness  <  6  year (AOR  =  5.29, 
CI 4.086, 15.894), seizure frequency of [1–11  per year 
(AOR = 1.34, CI 1.414, 4.360), ≥1/month (AOR = 7.83, 
CI 3.523, 17.400)], polypharmacy (AOR  =  7.63, CI 
2.741, 21.264) and difficulties of adherence to AEDs 
(AOR  =  4.80, CI 2.568, 8.964) were factors statistically 
significant with depression at p value <0.05 (Table 2).
Discussion
The aim of this study was to assess the prevalence and 
associated factors of depression among people with epi-
lepsy at Gondar University Hospital. In this study, the 
prevalence of depression was found to be 45.2 %. Out of 
these (29.6 %) mild, (14.8 %) moderate and (0.8 %) were 
severe depression. This result is similar with the study 
done in Poland (49.2 %) [21], Mexico (42.7 %) [22], Nige-
ria (42, 45 %) [23] and Ethiopia (49.3 %) [16]. The results 
of this study confirm the study done elsewhere as depres-
sion is a common co morbid psychiatric disorder among 
epileptic patients.
This figure (45.2 %) is lower than the study carried out 
in Korea (62 %) [19], Iraq (51.6 %) [24], Pakistan (60 %) 
Table 1 Distribution of  participants by  their socio-demo-




 Male 255 63
 Female 150 37
Age
 18–24 165 40.7
 25–34 123 30.4
 35–44 87 21.5
 ≥45 30 7.4
Educational status
 Can’t read and write 117 28.9
 Primary 195 48.1
 Secondary 51 12.6
 College and above 42 10.4
Religion
 Orthodox 372 91.9
 Muslim 33 8.1
Marital status
 Married 246 60.7
 Single 117 28.9
 Divorced/widowed 42 10.3
Ethnicity
 Amhara 384 94.8
 Tiger 21 5.2
Employment
 Government 27 6.7
 Private 240 59.2
 Student 66 17.8
 Unemployed 72 16.3
Residence
 Rural 192 47.4
 Urban 213 52.6
Social support
 High 249 61.4
 Moderate 93 23
 Low 63 15.6
Perceived stress
 Low 189 46.7
 High 216 53.3
Age at onset of disease in year
 <6 18 4.4
 6–11 45 11.1
 12–17 111 27.4
 18–24 111 27.4
 25–34 75 18.5
 ≥35 45 11.1
Duration of the disease
 <1 39 9.6
 2–5 144 35.6
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[25], Gaza (63  %) [26], and Nigeria (85.5  %) [27]. This 
variation may be due to using different diagnostic crite-
ria or different rating scales in diagnosing depression and 
recruiting epileptic patients with different seizure types, 
variable frequency and severity, and with different antie-
pileptic medications. For example study in Pakistan used 
ICD-10 and their study sample is small (100) as com-
pared to this study which may over estimated the preva-
lence of depression and in Gaza 64.5 % of study subject 
have epileptic fits uncontrolled type which contribute for 
the high depression.
In contrast, it is higher than the study done in USA 
(9.5) [28], Bosnia (34 %) [29], Thai (20 %) [30] and Egypt 
(25.5 %) [31]. The possible explanations for the variation 
may be due to use of different tools, (e.g., Hamilton Rat-
ing Scale for Depression (HRSD), Composite Interna-
tional Diagnostic Interview Short Form (CIDI-SF), use 
of different cutoff points, geographical areas and cultures 
of the study subject In Egypt out of all the study subject 
100 were health individual taken for comparison which 
may lower the prevalence of depression, in USA they 
used the Hospital Anxiety and Depression scale was used 
which has different cutoff point and again the geographi-
cal, infrastructure, economic development are different 
which contribute to lower the symptom of depression 
and in Bosnia they used prospective.
Regarding the associated factors, those patients 
who cannot read and write had more than eight times 
(AOR  =  8.32, CI 4.826, 14.294) odds of depression as 
compared to those patients who had educational status 
of college and above. Those patients who had educational 
status of primary (AOR = 6.02, CI 3.727, 9.292) and sec-
ondary (AOR = 4.00, CI 4.102, 8.251) had more than six 
and four times odds of depression as compared to those 
patients who had educational status of college and above 
respectively. These results were consistent with the previ-
ous study [16, 24, 29]. This is due to the fact that those 
patients with lower educational status may have poor 
coping strategies to their illness, which in turn to social 
isolation, poor adherence to their AEDs, school dropout 
that impaired their cognition and contributes to poorer 
psychological adjustment that they face in life.
Those patients with high perceived stress had more 
than six times (AOR  =  6.21, CI 3.691, 10.442) odds of 
depression as compared to those patients who had low 
perceived stress. This may be due to the fact that those 
individual with high perceived stress may have poorer 
psychological adjustment when they face different stress 
causing problems such as perceived stigma, unemploy-
ment, lower educational status and seizure frequency in 
their life that may be the cause for the comorbid psychi-
atric illness. Study shows that the most frequent kinds of 
stressor seem to be associated with depression were: situ-
ations that lower self-esteem, situations where a person is 
frustrated in the reaching of a certain goal and any single 
stressor of overwhelming magnitude [32]. A large body 
of research has also indicated that stress may lead to bio-
chemical changes in the brain, which in turn to induce 
depression [33]. A cross sectional study reported by S.A. 
Lee et al. revealed that out of the total 54.7 % of the study 
explained by variance, perceived stress alone account for 
38.8 % for depression and the remaining all other varia-
bles account for 15.9 % (that is social support account for 
6.8 %, anxiety for 3.9 %, and the remaining three variables 
(self-efficacy, employment status and age) accounted for 
5.2 % [19].
Those patients who had disease onset of less than 
6 years had more than five times (AOR = 5.29, CI 4.086, 
15.894) odds of depression than those patients who had 
disease onset at age of 35 years and above. These results 
were consistent with the previous studies done in Gaza 
[33]. As different literature revealed epilepsy imposes a 
substantial burden on the patient their families, the com-
munity, and society as a whole [1, 2, 5]. This increased 
burden is represented in many domains of their life such 
as physical health [5], psychosocial well-being [1, 3, 16] 
and economic problem [21, 27]. In our study the study 
subjects may not have enough coping mechanisms to 
these different problems because at early stage of life they 
may not have high level of education and experience that 
help them to cope up with different cultural belief, stigma 
and illness that contributed to co morbid psychiatric ill-
nesses. This result indicates that those study participants 
who had early onset of the disease in their life had more 




 6–10 117 28.9
 ≥11 105 25.9
Seizure frequency per year
 0 84 20.7
 1–11 per year 291 71.8
 ≥12 per year 30 7.4
Therapy (number of drug)
 Mono-pharmacy 309 76.3
 Poly-pharmacy 96 23.7
Difficulties of adherence to AEDs
 Yes 132 32.6
 No 273 67.4
Family history of mental illness
 Yes 18 4.4
 No 387 95.6
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Those patients who had seizure frequency of twelve 
and above had around eight times (AOR = 7.83, CI 3.523, 
17.400) odds of depression as compared to those patients 
who had no seizure frequency and those patients who had 
seizure frequency of one and above per year were more 
than one times (AOR = 1.34, CI 1.414, 4.360) more likely 
to develop depression than those patients who had no 
seizure frequency. These results were consistent with the 
previous studies [22, 23, 31, 33]. The possible reason may 
be since the symptoms and signs of epilepsy are peculiarly 
unhidden, unpredictable and not easy to understand. This 
difficulties of understanding where and when the seizure 
occur may associated with socially unacceptable sign such 
as loss of stool, urine, foaming from the mouth and tongue 
biting were evident that lead epileptic patient to develop 
different psycho-social problem including depression.
Those patients who used poly-pharmacy had more 
than seven times (AOR = 7.63, CI 2.741, 21.264) odds of 
Table 2 Factors associated with depression (bivariate and multivariate) analysis, at UoGH, 2014
** Statistically significant using a forward stepwise regression method with p value of Hosmer and Lemeshow goodness fit test 0.344
Explanatory variables Depression
Yes N (%) No N (%)
COR (95 % CI) AOR (95 % CI) P value
Age
 18–24 66 (40) 99 (60) 0.67 (0.305, 1.455)
 25–34 51 (41.5) 72 (58.5) 0.71 (0.318, 1.577)
 35–44 51 (58.6) 36 (41.4) 1.42 (0.616, 3.259)
 ≥45 15 (50) 15 (50) 1
Educational status
 Can’t read and write 57 (48.7) 60 (51.3) 5.70 (2.233, 14.551) 8.32 (4.826, 14.294)** <0.001
 Primary 90 (46.2) 105 (53.8) 5.14 (2.072, 12.763) 6.02 (3.727, 9.292)** <0.001
 Secondary 30 (58.8) 21 (41.2) 8.57 (3.064, 23.974) 4.00 (4.102, 8.251)** 0.005
 College and above 6 (14.3) 36 (85.7) 1 1
Social support
 High 105 (42.2) 144 (57.8) 1
 Moderate 42 (45.2) 51 (54.8) 1.13 (0.699, 1.825)
 Low 36 (57.142.9) 27 (6.7) 1.83 (1.046, 3.197)
Perceived stress
 Low 51 (27) 138 (73) 1 1 <0.001
 High 132 (61.1) 84 (38.9) 4.25 (2.789, 6.484) 6.21 (3.691, 10.442)**
Age at onset of the disease in year
 <6 15 (83.3) 3 (0.716.7) 2.50 (0.625, 9.996) 5.29 (4.086, 15.894)** <0.001
 6–11 24 (53.3) 21 (46.7) 0.57 (0.244, 1.341) 0.95 (0.287, 3.169) 0.939
 12–17 36 (32.4) 75 (67.6) 0.24 (0.115, 0.501) 0.55 (0.213, 1.413) 0.214
 18–24 45 (40.5) 66 (59.5) 0.34 (0.165, 0.705) 0.85 (0.343, 2.153) 0.734
 25–34 33 (44) 42 (56) 0.39 (0.182, 0.848) 0.84 (0.330, 2.153) 0.720
 ≥35 30 (66.7) 15 (33.3) 1 1
Seizure frequency per year
 0 21 (25) 63 (75) 1 1 1
 1–11 per year 147 (50.5) 144 (49.5) 3.06 (1.776, 5.280) 1.34 (1.414, 4.360)** 0.022
 ≥12per year 15 (50) 15 (50) 3.00 (1.257, 7.157) 7.83 (3.523, 17.400)** <0.001
Therapy (number of drug)
 Mono-pharmacy 132 (42.7) 177 (57.3) 1 1 <0.001
 Poly-pharmacy 51 (53.1) 45 (46.9) 5.34 (1.484, 19.389) 7.63 (2.741, 21.264)**
Difficulties of adherence to AEDs
 Yes 81 (61.4) 51 (38.6) 2.66 (1.736, 4.083) 4.80 (2.568, 8.964)** <0.001
 No 102 (37.4) 171 (62.6) 1 1
Family history of mental illness
 Yes 9 (50) 9 (50) 1.22 (0.476, 3.151)
 No 174 (40.3) 258 (59.7) 1
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depression than those patients who had mono-pharmacy. 
These results were consistent with the previous studies 
[29, 31]. This may be due to side effect of AEDs such as 
Phenobarbital as majority of our study participants used 
it.
Those patients who had difficulties of adherence to 
their AEDs had around five times (AOR = 4.80, CI 2.568, 
8.964) odds of depression than those patients who adhere 
to their AEDs. The possible reason may be those patients 
who had difficulties of adherence to their AEDs may 
result in breakthrough seizures that may lead an individ-
ual to develop depression. Most studies show that uncon-
trolled seizures are associated with a higher prevalence 
of depression than seizure free patients [34]. Studies 
have shown a bidirectional interaction between epilepsy 
and depression with up to 60  % of epileptic patients 
develop depression and depression also increase risk of 
epilepsy up to 3–7 fold [16, 21]. Different studies reviled 
the relapse of seizures after discontinuation of AEDs and 
withdrawal of AEDs [35].
Strength of the study
This study is the first of its kind in the study area to show 
the prevalence of depression among individual with 
epilepsy.
Limitations of the study
This study has some important limitations that should 
be kept in mind when interpreting the results. First, 
the cross-sectional nature of the study design does not 
confirm definitive cause and effect relationship. Sec-
ond the symptom similarity of depression and epilepsy, 
the adverse effects of AEDs overlap with symptoms of 
depression (such as fatigue, sleep disturbance, weight 
gain and memory problems) may over represent the 
problem. In addition, some of the independent variables 
like Seizure frequency, duration of illness and family his-
tory of mental illness relays on patient’s past history that 
might have recalled bias. Finally, some variables were 
assessed with single questions, for example, the diffi-
culties of adherence to their AEDs that may lead some 
patients to respond improperly.
Conclusion
Overall, the prevalence of depression was found to be 
high. Lower education status, early onset of illness, 
seizure frequency, poly-pharmacy and difficulties of 
adherence to AEDs were associated independently with 
depression. These findings add important evidence to 
the existing scant study in Sub-Saharan Africa and other 
developing countries on the psychological aspect of an 
individual with epilepsy. Stress reduction strategies (e.g., 
relaxation, exercise) particularly for those who had early 
onset of the illness and strengthening the educational sta-
tus of the participants were suggested in the clinical care 
setting to enhance their adherence to AEDs and control 
seizure frequency. Additional researches with qualita-
tive and quantitative study methods are also suggested, 
in order to explore the relation of socio-demographic and 
depression.
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